Cargando…

Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review

Background: Epilepsy affects 70–90% of patients with tuberous sclerosis complex (TSC). In one-third of them, the seizures become refractory to treatment. Drug-resistant epilepsy (DRE) carries a significant educational, social, cognitive, and economic burden. Therefore, determining risk factors that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miszewska, Dominika, Sugalska, Monika, Jóźwiak, Sergiusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658289/ https://www.ncbi.nlm.nih.gov/pubmed/34884198 http://dx.doi.org/10.3390/jcm10235495

Ejemplares similares

Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex—A Systematic Review
por: Sugalska, Monika, et al.
Publicado: (2021)

Epilepsy and Language Development in 8–36-Month-Old Toddlers with Tuberous Sclerosis Complex
por: Foryś-Basiejko, Małgorzata, et al.
Publicado: (2022)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Editorial: Tuberous Sclerosis Complex – Diagnosis and Management
por: Jozwiak, Sergiusz, et al.
Publicado: (2021)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
por: Moavero, Romina, et al.
Publicado: (2020)

Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
por: Kotulska, Katarzyna, et al.
Publicado: (2020)

Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
por: Nabbout, Rima, et al.
Publicado: (2018)

Early Vascular Aging in Children With Tuberous Sclerosis Complex
por: Skrzypczyk, Piotr, et al.
Publicado: (2021)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

Tuberous Sclerosis Complex Patients’ Needs and Difficulties—Results of TAND Questionnaire Analysis in Polish Adult Population
por: Marcinkowska, Anna B., et al.
Publicado: (2022)

Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review
por: Menezes, Catarina Ester Gomes, et al.
Publicado: (2023)

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
por: Słowińska, Monika, et al.
Publicado: (2018)

Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
por: Specchio, Nicola, et al.
Publicado: (2020)

Epilepsy in adult patients with tuberous sclerosis complex
por: Vignoli, Aglaia, et al.
Publicado: (2021)

A case of tuberous sclerosis complex revealed by epilepsy
por: Koné, Noukhoum, et al.
Publicado: (2017)

TLR7 activation in epilepsy of tuberous sclerosis complex
por: Dombkowski, Alan A., et al.
Publicado: (2019)

Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry
por: Nabbout, Rima, et al.
Publicado: (2021)

Current role of surgery for tuberous sclerosis complex‐associated epilepsy
por: Specchio, Nicola, et al.
Publicado: (2022)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase
por: Malik, Anna R., et al.
Publicado: (2015)

Independent temporal lobe epilepsy in patients with tuberous sclerosis complex
por: Liu, Tinghong, et al.
Publicado: (2022)

Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children
por: Park, Soyoung, et al.
Publicado: (2017)

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
por: Schubert-Bast, Susanne, et al.
Publicado: (2021)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018)

Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness
por: Kingswood, J Chris, et al.
Publicado: (2019)

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
por: Fogarasi, Andras, et al.
Publicado: (2016)

Measuring Health-Related Quality of Life in Tuberous Sclerosis Complex – Psychometric Evaluation of Three Instruments in Individuals With Refractory Epilepsy
por: de Vries, Petrus J., et al.
Publicado: (2018)

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
por: Vergeer, Menno, et al.
Publicado: (2019)

Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study
por: Almobarak, Sulaiman, et al.
Publicado: (2018)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
por: Sauter, Matthias, et al.
Publicado: (2021)

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
por: Kingswood, J. Chris, et al.
Publicado: (2021)

Epilepsy in Children with Tuberous Sclerosis Complex: A Prospective Observational Study in Bangladesh
por: Rahman, Md Mizanur, et al.
Publicado: (2020)

Infantile Hemiconvulsion-Hemiplegia and Epilepsy (IHHE) in a boy with tuberous sclerosis complex
por: Moschopoulos, Chariton, et al.
Publicado: (2021)

Exosomes in Epilepsy of Tuberous Sclerosis Complex: Carriers of Pro-Inflammatory MicroRNAs
por: Cukovic, Daniela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avmn6f0v47bedq4cle7phe995v